SUSANA BELL: Open Payments
NPI 1770605008 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,339 in 201 payments from 36 companies in 2025. Trend: 2023 $2,852 · 2024 $3,890 · 2025 $4,339
Food & beverage: $4,064Education: $275
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $420 |
| Janssen Biotech, Inc. | 16 | $343 |
| Daiichi Sankyo Inc. | 16 | $295 |
| GlaxoSmithKline, LLC. | 9 | $278 |
| Astellas Pharma US Inc | 15 | $232 |
| SOBI, INC | 11 | $218 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $193 |
| Exelixis Inc. | 8 | $178 |
| PFIZER INC. | 9 | $166 |
| PharmaEssentia USA Corporation | 6 | $165 |
Products named: ENHERTU, OJJAARA, CABOMETYX, INJECTAFER, Vonjo, FRUZAQLA, BESREMI, RYBREVANT.
Industry payments across CA — which companies pay providers there.
